Shareholder Information

Shares Issued

As at 5 October 2017, the number of shares in issue was 356,042,854.

Significant Shareholders

On the date of Admission
Shareholder Number Ordinary
Shares %
Flascherberg Capital Anstalt 27,996,487 7.86
Craig Auringer 31,407,913 8.82
Ron Valk 17,131,193 4.81
Plum Capital 11,692,863 3.28
43 North LLC 11,371,429 3.19

Director Shareholdings

On the date of Admission
Director Number Ordinary
Shares %
Dr. Vladislav Sandler 40,451,210 11.36
Alexis Sandler 75,090,685 21.09
Peter Redmond 5,040,714 1.41
Robin Campbell 1,142,857 0.32
Lawrence Pemble - -

Shares Not In Public Hands

Insofar as it is aware, as at Admission, 72.76% of the Company's securities was not in public hands.

Uk City Code On Takeovers And Mergers

The Company is subject to the provisions of the City Code on Takeover and Mergers.

Shareholder Circulars

05 June 2018 Notice of AGM to held on 27 June 2018

Other Exchanges And Trading Platforms

Hemogenyx Pharmaceuticals Plc has not applied or agreed to have any of it securities admitted or traded on any other exchanges or trading platforms.